Maculatin 1.1 |
GLFVGVLAKVAAHVVPAIAEHF |
Pore |
Dye leakage experiment and MD simulations (Chen and Mark, 2011; Sani et al., 2013) |
Caerin 1.1 |
GLLSVLGSVAKHVLPHVVPVIAEHL |
Pore |
MD simulations (Chen and Mark, 2011) |
Cateslytin |
RSMRLSFRARGYGFR |
Pore |
MD simulations and Patch-clamp experiment (Jean-François et al., 2008) |
Gramicidin A |
VGALAVVVWLWLWLW |
Pore |
NMR (Urry, 1971; Ketchem et al., 1993) |
Alamethicin |
PAAAAQAVAGLAPVAAEQ |
Barrel stave pore |
Ion conductance experiment and statistical analysis (Boheim, 1974; Laver, 1994) |
Magainin H2 |
IIKKFLHSIWKFGKAFVGEIMNI |
Pore |
Ion conductance experiment and MD simulations (Matsuzaki, 1998; Leontiadou et al., 2006) |
Melittin |
GIGAVLKVLTTGLPALISWIKRKRQQ |
Toroidal pore |
Dye leakage and grazing-Angle X-Ray Anomalous Diffraction and MD simulations (Yang et al., 2001; Sengupta et al., 2008; Lee et al., 2013; Leveritt et al., 2015) |
Protegrin 1 |
RGGRLCYCRRRFCVCVGR |
Pore |
Ion conductance experiment (Sokolov et al., 1999) |
LL-37 |
LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES |
Toroidal pore |
NMR (Henzler Wildman et al., 2003) |
Indolicidin |
ILPWKWPWWPWRR |
Pore |
Ion conductance experiment (Falla et al., 1996) |
Pardaxin 1 |
GFFALIPKIISSPLFKTLLSAVGSALSSSGEQE |
Barrel stave pore |
NMR (Porcelli et al., 2004; Ramamoorthy et al., 2010) |
MSI peptide |
GIGKFLHSAKKFGKAFVGEIMNS |
Carpet |
NMR (Lee et al., 2015) |
Citropin 1.1 |
GLFDVIKKVASVIGGL |
Carpet |
MD simulations (Chen and Mark, 2011) |
Aurein 1.2 |
GLFDIIKKIAESF |
Carpet |
Quartz crystal microbalance with dissipation, vesicle dye leakage and atomic force microscopy experiments and MD simulations (Chen and Mark, 2011; Fernandez et al., 2012) |
B2088 |
(RGRKVVRR)2KK |
Carpet |
MD simulations (Li et al., 2013) |
PL-5 |
Ac-KWKSFLKTFKS-A-AKTVLHTALKAISS-amide |
|
In clinical trials. ProteLight-Pharmaceuticalal, 2016a
|